Frontlight ResearchEarly access
Trial site
The Second Norman Bethune Hospital of Jilin University
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- Coronary artery disease2 trials
- IgA nephropathy1 trial
- Ovarian cancer1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 2/32 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
- Amgen1 trial
- Jiangsu Simcere Pharmaceutical Co., Ltd.1 trial
- Shanghai Jiaolian Drug Research and Development Co., Ltd1 trial
- Shanghai Pharmaceuticals Holding Co., Ltd1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
Closed trials
Completed
Completed
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026